Report cover image

Peptide Synthesis Market by Reagent (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer), Technology (Solid-phase, Solution-phase, Hybrid & Recombinant), End User (Pharma, Biotech, CRO) - Global Forecast to 2026

Publisher MarketsandMarkets
Published Jan 06, 2022
Length 228 Pages
SKU # MKMK16905976

Description

Peptide Synthesis Market by Reagent (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer), Technology (Solid-phase, Solution-phase, Hybrid & Recombinant), End User (Pharma, Biotech, CRO) - Global Forecast to 2026

The global peptide synthesis market is projected to reach USD 730 million by 2026 USD 515 million in 2021, at a CAGR of 7.2% during the forecast period. Growth in this market is driven by the increasing use of peptides in pharmaceutical drugs, increase in research activities and availability of funding for R&D, and the development of advanced automated peptide synthesizers.

“The reagents segment accounted for the highest growth rate in the peptide synthesis market, by product & service, during the forecast period”

In 2020, the reagents segment accounted for the highest growth rate. The peptide synthesis reagents market is further segmented into resins, amino acids, coupling reagents, dyes and fluorescent labeling reagents, and other reagents (such as protecting reagents, linkers, buffers, solvents, and solutions). The requirement of reagents in bulk quantities, especially in the most preferred solid-phase peptide synthesis method of peptide synthesis, is another factor responsible for the large share of this segment in the peptide synthesis market. GenScript Biotech Corporation (China), Thermo Fisher Scientific (US), AAPPTec (US), Bachem Holding AG (Switzerland), Kaneka Corporation (US), Biotage AB (Sweden), CEM Corporation (US), Mesa Laboratories, Inc. (Sweden), Advanced ChemTech (US), and Merck KGaA (Germany) are some of the major players operating in the peptide synthesis reagents market.

“Asia Pacific: The fastest-growing region in the peptide synthesis market”

The peptide synthesis market is segmented into North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA). The high growth in this market is attributed to growing R&D funding, rising research activity, and increasing investments by pharmaceutical and biotechnology companies in enhancing equipment and technology of production. The increasing applications of peptides in therapeutics is further expected to drive the peptide synthesis market in the Asia Pacific region.

The primary interviews conducted for this report can be categorized as follows:
By Respondent: Supply Side- 80% and Demand Side 20%
By Designation: C-level - 55%, D-level - 20%, and Others - 25%
By Region: North America -50%, Europe -20%, Asia-Pacific -20%, RoW -10%

List of Companies Profiled in the Report:
Bachem Holding AG (Switzerland)
Thermo Fisher Scientific (US)
Merck KGaA (Germany)
GenScript Biotech Corporation (China)
Kaneka Corporation (Japan)
Biotage AB (Sweden)
Syngene International Ltd. (India)
Mesa Laboratories inc. (US)
CEM Corporation (US)
ProteoGenix (France)
Bio-Synthesis Inc. (US)
Dalton Pharma Services (Canada)
AAPPTec (US)
vivitide (US)
AnyGen Co., Ltd. (South Korea)
CSBio (US)
Advanced Chemtech (US)
Luxembourg Bio Technologies Ltd. (Israel)
JPT Peptide Technologies GmbH (Germany)
AmbioPharm Inc. (US)
Aurigene Pharmaceutical Services Ltd. (India)
Corden Pharma International (Germany)
ChemPep Inc. (US)
CPC Scientific Inc. (US)
Purolite Pvt Ltd. (US)

Research Coverage:

This report provides a detailed picture of the peptide synthesis market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall peptide synthesis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, trends, and opportunities.

Table of Contents

228 Pages
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
    • SUMMARY OF CHANGES
    • RESEARCH DATA
    • MARKET ESTIMATION METHODOLOGY
    • MARKET GROWTH RATE PROJECTIONS
    • DATA TRIANGULATION
    • RESEARCH ASSUMPTIONS
    • RISK ANALYSIS
  • EXECUTIVE SUMMARY
    • PEPTIDE SYNTHESIS MARKET OVERVIEW
    • NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE AND COUNTRY (2020)
    • PEPTIDE SYNTHESIS MARKET SHARE, BY TECHNOLOGY (2020)
    • PEPTIDE SYNTHESIS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    • PEPTIDE SYNTHESIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • INTRODUCTION
    • MARKET DYNAMICS
    • RANGES/SCENARIOS
    • IMPACT OF THE COVID-19 OUTBREAK ON THE PEPTIDE SYNTHESIS MARKET
    • TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • VALUE CHAIN ANALYSIS
    • TECHNOLOGICAL ANALYSIS
    • PATENT ANALYSIS
    • ECOSYSTEM ANALYSIS OF THE PEPTIDE SYNTHESIS MARKET
    • PORTER'S FIVE FORCES ANALYSIS
    • REGULATORY ANALYSIS
    • INTRODUCTION
    • REAGENTS
    • EQUIPMENT
    • SERVICES
    • INTRODUCTION
    • SOLID-PHASE PEPTIDE SYNTHESIS (SPPS)
    • SOLUTION-PHASE PEPTIDE SYNTHESIS
    • HYBRID & RECOMBINANT TECHNOLOGY
    • INTRODUCTION
    • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS AND CONTRACT RESEARCH ORGANIZATIONS (CDMOS & CROS)
    • ACADEMIC & RESEARCH INSTITUTES
    • INTRODUCTION
    • NORTH AMERICA
    • EUROPE
    • ASIA PACIFIC (APAC)
    • LATIN AMERICA
    • MIDDLE EAST & AFRICA
    • OVERVIEW
    • KEY PLAYERS STRATEGIES/RIGHT TO WIN
    • MARKET SHARE ANALYSIS
    • REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
    • COMPANY EVALUATION QUADRANT
    • COMPANY EVALUATION QUADRANT: START-UPS/SMES
    • COMPANY PRODUCT FOOTPRINT
    • COMPANY GEOGRAPHIC FOOTPRINT
    • COMPETITIVE SCENARIO
    • KEY PLAYERS
    • OTHER PLAYERS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us